Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Clarithro TM

Active ingredients: clarithromycin

What it is used for

Clarithromycin (Clarithro) is indicated for use in adults and children older than 12 years for the treatment of mild to moderately severe infections caused by susceptible strains of the designated micro-organisms in the conditions listed below.,1. Acute streptococcal pharyngitis.,2. Community acquired pneumonia due to Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila and Streptococcus pneumoniae (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE regarding sensitivity testing);,3. Uncomplicated skin and skin structure infections due to Staphylococcus aureus or Streptococcus pyogenes (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE regarding sensitivity testing);,4. Disseminated or localised mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare and skin and skin structure infections due to Mycobacterium chelonae. Clarithromycin should be used in combination with other anti-mycobacterial agents.,5. Prevention of disseminated Mycobacterium avium complex infection in HIV-infected adults with CD4 lymphocyte counts < 75 cells/mm3 (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). Disseminated infection due to Mycobacterium avium complex should be excluded by a negative blood culture prior to commencement of prophylaxis.,6. Acute bacterial exacerbation of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae.,7. Combination therapy for the treatment of peptic ulcer disease associated with Helicobacter pylori infection.,Clarithromycin (Clarithro) is indicated for use in children for the treatment of mild to moderately severe infections caused by susceptible strains of the designated micro-organisms in the conditions listed below.,1. Acute streptococcal pharyngitis and tonsillitis caused by Streptococcus pyogenes.,2. Community acquired pneumonia including infections due to Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophilia.,3. Skin and skin structure infections (e.g. impetigo).,4. Disseminated or localised infections due to Mycobacterium avium or Mycobacterium intracellulare in immuno-compromised children, including those with HIV infection or AIDS.,5. Acute otitis media.,Note.,1. Penicillins are the drug of first choice in the treatment of acute otitis media.,2. Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections including prophylaxis of rheumatic fever. Clarithromycin appears to be as effective as phenoxymethylpenicillin in the eradication of streptococci from the nasopharynx, however substantial data establishing the efficacy of clarithromycin in the subsequent prevention of rheumatic fever are not available at present.,3. There is insufficient evidence of efficacy to support the use of clarithromycin in acute bronchitis in young children.,4. The data presented on infections of skin and skin structure were confined largely to mild to moderate infections such as impetigo.,Consideration should be given to official guidance on the appropriate use of antibacterial agents.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store below 25 degrees Celsius
  • Shelf lifetime is 2 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Yellow, oval film-coated tablet 7.8mm x 14.9mm

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient clarithromycin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.